Get the full picture
Sign in to uncover key details.
PDX Pharmaceuticals
Manufacturing · Oregon, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3303 S Bond Ave, Portland, Oregon, 97239...Phone Number
(503) 418-0483Website
www.pdxpharm.comRevenue
<$5 MillionIndustry
About PDX Pharmaceuticals
PDX Pharmaceuticals, also known as Raksa Therapeutics, is a biopharmaceutical company focused on developing innovative nanotherapeutic pipelines to enhance cancer-specific immunity. The company utilizes its proprietary nanoparticle platform to create next-generation combination immunotherapies for various types of cancer, including lung and breast cancer. PDX is currently conducting IND enabling studies for its drug candidates, ARAC-02 and AIRISE-02, with plans to initiate clinical trials by 2025. Their target clients include healthcare providers and patients seeking advanced cancer treatment options.Explore more
PDX Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to PDX Pharmaceuticals
Compare insights from companies similar to PDX Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
PDX Pharmaceuticals Tech Stack
A closer look at the technologies used by PDX Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PDX Pharmaceuticals
Sign Up For FreeTo access detailed company insights
PDX Pharmaceuticals, also known as Raksa Therapeutics, is a biopharmaceutical company focused on developing innovative nanotherapeutic pipelines to enhance cancer-specific immunity. The company utilizes its proprietary nanoparticle platform to create next-generation combination immunotherapies for various types of cancer, including lung and breast... Read More
